NOVARTIS AG-REG (1NOVN.MI) Stock Price & Overview
BIT:1NOVN • CH0012005267
Current stock price
The current stock price of 1NOVN.MI is 132 EUR. Today 1NOVN.MI is down by -2.22%. In the past month the price increased by 13.79%.
1NOVN.MI Key Statistics
- Market Cap
- 253.281B
- P/E
- 16.94
- Fwd P/E
- 16.83
- EPS (TTM)
- 7.79
- Dividend Yield
- 3.06%
1NOVN.MI Stock Performance
1NOVN.MI Stock Chart
1NOVN.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1NOVN.MI.
1NOVN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 1NOVN.MI. 1NOVN.MI scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
1NOVN.MI Earnings
On February 4, 2026 1NOVN.MI reported an EPS of 2.03 and a revenue of 13.34B. The company missed EPS expectations (-0.17% surprise) and missed revenue expectations (-4.89% surprise).
1NOVN.MI Forecast & Estimates
34 analysts have analysed 1NOVN.MI and the average price target is 132.6 EUR. This implies a price increase of 0.46% is expected in the next year compared to the current price of 132.
For the next year, analysts expect an EPS growth of 0.69% and a revenue growth 2.75% for 1NOVN.MI
1NOVN.MI Groups
Sector & Classification
1NOVN.MI Financial Highlights
Over the last trailing twelve months 1NOVN.MI reported a non-GAAP Earnings per Share(EPS) of 7.79. The EPS increased by 14.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.83% | ||
| ROA | 12.6% | ||
| ROE | 30.31% | ||
| Debt/Equity | 0.64 |
1NOVN.MI Ownership
1NOVN.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 8.96 | 185.977B | ||
| SAN | SANOFI | 8.98 | 185.711B | ||
| 1SAN | SANOFI | 8.95 | 184.552B | ||
| UNC | UCB SA | 25.32 | 50.65B | ||
| UCB | UCB SA | 24.68 | 50.164B | ||
| 1MRK | MERCK KGAA | 13.45 | 48.348B | ||
| MRK | MERCK KGAA | 13.23 | 48.217B | ||
| BAYN | BAYER AG-REG | 8.45 | 39.503B | ||
| 1BAYN | BAYER AG-REG | 8.44 | 38.825B | ||
| IPN | IPSEN | 12.71 | 13.217B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.681B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 15.58 | 9.419B | ||
| VIRP | VIRBAC SA | 16.39 | 2.806B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1NOVN.MI
Company Profile
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Info
IPO: 2001-05-07
NOVARTIS AG-REG
Lichtstrasse 35
Basel BASEL-STADT CH
Employees: 75883
Phone: 41613241111
NOVARTIS AG-REG / 1NOVN.MI FAQ
What does NOVARTIS AG-REG do?
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
What is the current price of 1NOVN stock?
The current stock price of 1NOVN.MI is 132 EUR. The price decreased by -2.22% in the last trading session.
What is the dividend status of NOVARTIS AG-REG?
NOVARTIS AG-REG (1NOVN.MI) has a dividend yield of 3.06%. The yearly dividend amount is currently 3.5.
How is the ChartMill rating for NOVARTIS AG-REG?
1NOVN.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Is NOVARTIS AG-REG (1NOVN.MI) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1NOVN.MI.
How many employees does NOVARTIS AG-REG have?
NOVARTIS AG-REG (1NOVN.MI) currently has 75883 employees.
Can you provide the market cap for NOVARTIS AG-REG?
NOVARTIS AG-REG (1NOVN.MI) has a market capitalization of 253.28B EUR. This makes 1NOVN.MI a Mega Cap stock.